Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 13/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TOP2A | P11388 | 3/20 | 0.42 |
| ▸ | TOP2B | Q02880 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23880708 | 0.99 | NISCH (0.52) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL23902257 | 0.92 | NISCH (0.51) | NISCH | |
| Hydrochloric Acid SCHEMBL23235794 | 0.91 | NISCH (0.50) | NISCH | |
| SCHEMBL23901926 | 0.89 | NISCH (0.43) | NISCHGAATSHRTOP2ATOP2B | |
| Hydrochloric Acid SCHEMBL34433953 | 0.88 | NISCH (0.42) | NISCHGAATSHRTOP2ATOP2B | |
| Hydrochloric Acid SCHEMBL23235872 | 0.88 | NISCH (0.42) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL23901805 | 0.85 | NISCH (0.65) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL23901955 | 0.81 | NISCH (0.41) | NISCH | |
| Hydrochloric Acid SCHEMBL23235827 | 0.81 | NISCH (0.40) | NISCH | |
| SCHEMBL23902154 | 0.78 | NISCH (0.51) | NISCHGAATSHRTOP2ATOP2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210309641-A1 | AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210309641-A1 | AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS | PAM, AMPD1, AMPD3 | NISCH 24/4885GAA 885/4885TSHR 1561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.